Count | |
| 5 | |
| 1 | |
Prazosin/administration & dosage/adverse effects/*therapeutic use | 1 |
Prazosin/administration & dosage/*analogs & derivatives/therapeutic use | 1 |
| 1 | |
| 3 | |
| 9 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
Prazosin/*analogs & derivatives/antagonists & inhibitors/metabolism | 1 |
Prazosin/analogs & derivatives/antagonists & inhibitors/metabolism | 1 |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 5 | |
| 3 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 10 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 4 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 3 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 10 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 14 | |
| 10 | |
| 2 | |
| 9 | |
| 4 | |
| 2 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 10 | |
| 1 | |
| 3 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 14 | |
| 2 | |
| 4 | |
| 1 | |
| 11 | |
| 2 | |
| 9 | |
| 2 | |
| 13 | |
| 1 | |